Aragen Bioscience has appointed Steven Lang as vice president, biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a contract research organization (CRO) focused on accelerating biologics product development with an integrated offering that includes antibody discovery and humanization, stable cell line development, recombinant protein production and purification, and differentiated diseases models.   “It’s my pleasure to welcome Dr. Steven Lang to Aragen.” said Axel Schleyer, chief execu...